BioSpace News Archive

Pharming Group N.V. announced that since the release of its update regarding cashless and other warrant exercises and bond conversions on 10 August 2017.

Vical had cash and investments of $35.2 million at September 30, 2017.

ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers, today announced that it has raised $200 million through a private placement.

TiGenix NV announces that the FDA has granted orphan drug designation (ODD) to Cx601 for the treatment of patients with fistulizing Crohn´s disease.

Our brains wire themselves up during development according to a series of remarkable genetic programs that have evolved over millions of years.

Stryker’s Spine division will introduce its Tritanium C Anterior Cervical Cage, a 3D-printed interbody fusion cage intended for use in the cervical spine, at the North American Spine Society (NASS) Annual Meeting, Oct. 25-28, 2017, in Orlando, Fla. (booth No. 500).

DIAGNOS Inc., a leader in early detection of critical health issues through the use of Artificial Intelligence, announces the closing of a second tranche of 2 units (each a “Unit”), for gross cash receipts of $100,000, as part of a private placement (“Private Placement”) initially announced on October 16, 2017.

Nevro today announced that it will release financial results for the third quarter of 2017 after market close on Monday, November 6, 2017.

Knopp Biosciences LLC today announced the renewal and expansion of its grant award from the National Institutes of Health Blueprint Neurotherapeutics Network to advance novel treatments for epilepsy.

MilliporeSigma has recognized a group of outstanding postgraduate students for their research and innovations in life science at an awards ceremony at the company’s new Life Science Center in Burlington, Massachusetts.